The effect of acutely induced hepatic failure on remifentanil and fentanyl blood levels in a pig model

European Journal of Anaesthesiology

Volumn 23, Issue 7, 2006, Pages 598-604

  Kostopanagiotou, G ^a   Markantonis, S L ^b   Arkadopoulos, N ^a   Andreadou, I ^b   Charalambidis, G ^b   Chondroudaki, J ^a   Costopanagiotou, C ^a   Smyrniotis, V ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Acute liver failure, opioid analgesics, fentanyl, remifentanil; Pharmacokinetics; Pig model

Indexed keywords

ANALGESIC AGENT; FENTANYL; OPIATE; REMIFENTANIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTRANSFORMATION; BLOOD SAMPLING; CONTINUOUS INFUSION; CONTROLLED STUDY; DEVASCULARIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; HEMODYNAMICS; INTENSIVE CARE UNIT; LIVER BLOOD FLOW; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; SWINE;

ACUTE DISEASE; ANIMALS; FEMALE; FENTANYL; HEMODYNAMIC PROCESSES; LIVER FAILURE; MODELS, ANIMAL; PIPERIDINES; SWINE;

EID: 33646510094     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506000135     Document Type: Article

References (27)

1. Lee WM. Medical progress. Acute liver failure. New Engl J Med 1993; 329: 1862-1872.
2. Fingerote RJ, Bain VG. Fulminant hepatic failure. Am J Gastroenterol 1993; 88: 1000-1010.
3. Caraceni P, Van Thiel DH. Acute liver failure. Lancet 1995; 345: 163-169.
4. Munoz SJ. Difficult management problems in fulminant hepatic failure. Sem Liv Dis 1993; 13: 395-413.
5. Schiodt FV, Atillasoy E, Shakil AO et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29-34.
6. Eisenhuber E, Madl C, Kramer L et al. Prognostic factors in acute liver failure. Wien Klin Wochenschr 1998; 110: 564-569.
7. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg 1993; 128: 677-682.
8. Sakabe T, Nakakimura K. Effects of anesthetic agents and other drugs on cerebral blood flow, metabolism, and intracranial pressure. In: Cottrell JE, Smith DS, eds. Anaesthesia and Neurosurgery, 3rd edn. St. Louis: Mosby, 1997: 152-160.
9. Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic agents. Ann Intern Med 1973; 78: 173-181.
10. Misfeldt BB, Jorgensen PB, Spotoft H, Ronde F. The effects of droperidol and fentanyl on intracranial pressure and cerebral perfusion pressure in neurosurgical patients. Br J Anaesth 1976; 48: 963-968.
11. Moss E, Powell D, Gibson RM, McDowall DG. Effects of fentanyl on intracranial pressure and cerebral perfusion pressure during hypocapnia. Br J Anaesth 1978; 50: 779-784.
12. Wendon J, Williams R. The practice of liver transplantation. In: Williams R, Portmann B, Tan KC, eds. Acute Liver Failure, Edinburgh: Churchill Livingstone, 1995: 93-103.
13. Boos DL, Stirt JA. Pharmacology. In: Sperry RJ, Stirt JA, Stone DJ, eds. Manual of Neuroanaesthesia Toronto: BC Decker, 1989: 37-66.
14. Tegeder I, Lotsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999; 37: 17-40.
15. Dershwitz M, Hoke JF, Rosow CE et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anaesthesiology 1996; 84: 812-820.
16. Navapurkar VU, Archer S, Gupta SK et al. Metabolism of remifentanil during liver transplantation. Br J Anaesth 1998; 81: 881-886.
17. Selinger K, Lanzo C, Sekut A. Determination of remifentanil in human and dog blood by HPLC with UV detection. J Pharm Biomed Anal 1994; 12: 243-248.
18. Gillespie TJ, Gandolfi AJ, Maiorino RM, Vaughan RW. Gas chromatographic determination of fentanyl and its analogues in human plasma. J Anal Toxicol 1981; 5: 133-137.
19. Haberer JP, Schoeffer P, Couderc E, Duvaldestin P. Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth 1982; 54: 1267-1270.
20. Hudson RJ, Tsomson IR, Cannon JE, Friesen RM, Meatherall RC. Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery. Anaesthesiology 1986; 64: 334-338.
21. Chism JP, Rickert DE. The pharmacokinetics and extrahepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions. Drug Metab Dispos 1996; 24: 34-40.
22. Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. J Pharmacol Exp Ther 1997; 281: 226-232.
23. Newsome PN, Plevris JN, Nelson LJ, Hayes PC. Animal models of fulminant hepatic failure: a critical evaluation. Liver Transplant 2000; 6: 21-31.
24. Hanid MA, MacKenzie RL, Jenner RE et al. Intracranial pressure in pigs with surgically induced acute liver failure. Gastroenterology 1979; 76: 123-131.
25. Kostopanagiotou G, Routsi C, Smyrniotis V et al. Alterations in bronchoalveolar lavage fluid during ischaemia-induced acute hepatic failure in the pig. Hepatology 2003; 37: 1130-1138.
26. Egan TD, Kuramkote S, Gong G, Zhang J, McJames SW, Bailey PL. Fentanyl pharmacokinetics in haemorrhagic shock: a porcine model. Anaesthesiology 1999; 91: 156-166.
27. Johnson KB, Kern SE, Hamber EA, McJames SW, Kohnstamm KM, Egan TD. Influence of haemorrhagic shock on remifentanil-A pharmacokinetic and pharmacodynamic analysis. Anaesthesiology 2001; 94: 322-332.